Home
Sunday, June 2, 2024 | 6:45 pm – 8:15 pm CT Supported by an independent educational grant from Takeda Pharmaceuticals, Inc. Join us in Chicago for a timely and important discussion on refractory metastatic colorectal cancer (mCRC). In this 90-minute symposium, a panel of experts in refractory mCRC will guide learners through a number of patient cases to build a strong foundation of information for using new and emerging therapies effectively within their clinical practice and enhance their patient